554341 ApS: Financial statements 2026
CVR: 37344281
Source: annual report 2026, Danish Business Authority
01/07/2025 – 30/06/2026
554341 ApS (CVR 37344281) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK 650,727 and a net result of DKK 2,376,322 compared with DKK 835,032 the year before. That is a decrease of 8.4% compared with the year before. Equity in the 2026 report amounted to DKK 10,724,051. The solvency ratio was 49.1%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 650,727
- Profit/Loss
- DKK 2,376,322
- Equity
- DKK 10,724,051
- Total Assets
- DKK 21,853,605
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | 651K | 2.4M | 10.7M | 1 |
| 2025 | - | 710K | 835K | 8.3M | 1 |
| 2024 | - | 165K | 2.1M | 7.5M | 1 |
| 2023 | - | 140K | 53K | 4.8M | 0 |
| 2022 | - | -125K | 536K | 4.7M | 0 |
Official annual report
Find more companies like 554341 ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2026
Address changed to Amaliegade 35, 1256 København K (September 4, 2026).
As of September 1, 2026, Anders Marcus Fredrik Poulsen is registered as adm. dir. of 554341 ApS.
As of September 1, 2026, Jens Frederik Hostrup-Henriksen has stepped down as adm. dir. of 554341 ApS.
About 554341 ApS
554341 ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named 416 ApS and Øjenhospitalet Danmark Pharma Aps. The management consists of Anders Marcus Fredrik Poulsen. The board consists of Morten Løw (chair), Jens Frederik Hostrup-Henriksen and Julie Wagner Hostrup-Henriksen. The company is owned by GYNGER OG KARRUSELLER ApS. According to the 2026 annual report, the company had an average of 1 employee. In 2026, the company reported a gross profit of DKK 650,727 and a net result of DKK 2,376,322 compared with DKK 835,032 the year before. Equity in the 2026 report amounted to DKK 10,724,051.